You are here

Stabilising rheumatoid arthritis patients

Since the launch of the first-to-market anti-TNF for the treatment of rheumatoid arthritis several other anti-TNF therapies were approved. Due to lack of experience, clinicians often switched to an alternative anti-TNF treatment before an optimum response was achieved.

It was our role to help optimise patient outcomes on any one anti-TNF treatment by increasing the length of time that a patient receives any one anti-TNF treatment and to decrease the percentage of patients switching between anti-TNFs thereby reducing the treatment withdrawals. To achieve these goals, we worked with a multi-disciplinary advisory group to develop and publish a step-by-step “how-to” algorithm for Musculoskeletal Care.

Since publication, the length of treatment increased by 12% and the rate of treatment withdrawal in the three months post publication of the algorithm decreased by 42% compared to the nine months before publication. An all-round success.

 

You might also like